A61P 1/06

Technology



back to "A61P 1/06" profile

More Results

Showing 1 to 20 of 83 results

Patent/Pub #TitleFiling DateIssue/Publication DatePatent Owner
2024/0307,497 ADIPONECTIN ALONE OR IN COMBINATION WITH EXTRACORPOREAL PHOTOPHERESIS (ECP) FOR IMMUNE RELATED ADVERSE EVENTS OF IMMUNE CHECKPOINT INHIBITORSDec 21, 23Sep 19, 24Mallinckrodt Pharmaceuticals Ireland Limited
2024/0156,880 BACTERIOTHERAPYAug 09, 23May 16, 24Not available
2024/0108,610 RECTAL ADMINISTRATION OF ROFLUMILAST FOR THE TREATMENT OF CROHN'S DISEASESep 08, 23Apr 04, 24Not available
2019/0277,833 ANTI-METHANOGENIC COMPOSITIONSMay 12, 17Sep 12, 19Not available
2013/0053,446 PHARMACEUTICAL PREPARATIONS HAVING INDIVIDUALIZED DOSAGE AND STRUCTURENov 06, 10Feb 28, 13RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY
2013/0039,981 Quick Dissolving, Long Acting Zinc Therapeutic FormulationsOct 25, 12Feb 14, 13Not available
2013/0017,262 IMMEDIATE/DELAYED DRUG DELIVERYMar 04, 11Jan 17, 13UNIVERSITY OF STRATHCLYDE
2012/0295,849 USE OF GLP-1 RECEPTOR AGONISTS FOR THE TREATMENT OF GASTROINTESTINAL DISORDERSJul 05, 12Nov 22, 12CEDARS-SINAI MEDICAL CENTER
2012/0264,799 INDANE-AMINE DERIVATIVES, THEIR PREPARATION AND USE AS MEDICAMENTSSep 29, 10Oct 18, 12LABORATORIOS DEL DR. ESTEVE, S.A.
2012/0252,824 Drug Combinations and Uses in Treating a Coughing ConditionApr 13, 12Oct 04, 12INFIRST HEALTHCARE LIMITED
2012/0225,012 COMPOSITION FOR HARD TISSUE REPAIRNov 18, 10Sep 06, 12MITSUI CHEMICALS, INC.
2012/0202,848 THERAPY OF AUTOIMMUNE COLITIS USING A TIP60 INHIBITORDec 02, 11Aug 09, 12THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA
2012/0172,442 METHODS FOR DECREASING THE INCIDENCE OF NECROTIZING ENTEROCOLITIS, COLIC, AND SHORT BOWEL SYNDROME IN AN INFANT, TODDLER, OR CHILDDec 21, 11Jul 05, 12Abbott Laboratories
2012/0172,443 NUTRITIONAL PRODUCTS INCLUDING A NOVEL FAT SYSTEM INCLUDING MONOGLYCERIDESDec 21, 11Jul 05, 12Abbott Laboratories
2012/0172,445 NUTRITIONAL PRODUCTS INCLUDING A NOVEL FAT SYSTEM INCLUDING FATTY ACIDSDec 21, 11Jul 05, 12Abbott Laboratories
2012/0164,139 Dopamine 3 receptor agonist and antagonist treatment of gastrointestinal motility disordersMar 06, 12Jun 28, 12BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
2012/0157,477 REVERSAL OF L-DOPA-INDUCED DYSKINESIA BY NEURONAL NICOTINIC RECEPTOR LIGANDSJun 15, 10Jun 21, 12Targacept, Inc.
2012/0142,677 Pyrrolidine Compounds Which Modulate The CB2 ReceptorDec 15, 09Jun 07, 12BOEHRINGER INGELHEIM INTERNATIONAL GMBH
2012/0129,820 NEW PHARMACEUTICAL COMPOSITIONS FOR TREATMENT OF RESPIRATORY AND GASTROINTESTINAL DISORDERSFeb 08, 10May 24, 12BOEHRINGER INGELHEIM INTERNATIONAL GMBH
2012/0121,562 NUTRITIONAL COMPOSITION FOR BREAST-FED INFANTS OR PETS WITH PROBIOTICS AND SELECTED NUTRIENTSJul 28, 10May 17, 12NESTEC S.A.

Showing 1 to 20 of 83 results